Real-time optical tracking of Complex I turnover using ultra-fast stopped flow technique  by Verkhovskaya, Marina & Belevich, Nikolay
S4.P23
The NADH:ubiquinone oxidoreductase from Escherichia coli
studied by means of FTIR spectroscopy
Batoul Sroura, Steimle Stefanb, Friedrich Thorstenb, Hellwig Petraa
aBioelectrochemistry and Spectroscopy Laboratory, UMR 7140, University
of Strasbourg, 1 rue Blaise Pascal, 67070 Strasbourg, France
bInstitute of Biochemistry, Albert-Ludwig's Freiburg University, Albertstrasse
21, D-79104 Freiburg, Germany
E-mail address: batoul.srour@etu.unistra.fr
The proton-pumping NADH:ubiquinone oxidoreductase (com-
plex I) is the ﬁrst and largest enzyme of the respiratory chain [1],
coupling the transfer of electrons from NADH to ubiquinone with
the translocation of protons across the membrane, thus contributing
to the generation of the proton motive force required for energy
consuming processes. This molecular mechanism is still under
debate although this protein has been under study for more than
40 years. To make further progress, FTIR and resonance Raman
spectroscopy are used to understand more about the structure and
the function of this protein [2]. The structure of complex I was
elucidated by the group of Sazanov in 2011 [3]. The structure
conﬁrmed that complex I consists of an unusual L-shaped structure
with a peripheral arm extending into the aqueous phase, that
includes all previously determined cofactors and a membrane part
embedded in the lipid bilayer, where proton translocation takes
place. There is evidence that the energy released by the redox
reaction is transmitted by conformational changes of a 110 Å
“horizontal” helix aligning the membrane arm [4]. In this work,
we are studying mutations in the membrane part of complex I
particularly in the NuoL subunit. First, the electrochemically in-
duced FTIR difference spectra have been obtained for the wild
type and for the NuoL mutants and the inﬂuence of these mutations
on the conformational control of the enzyme has been shown.
Furthermore, the hydrogen deuterium exchange kinetics was
performed on the wild type and the mutants which help to moni-
tor the ﬂexibility, hydrogen bonding, as well as conformational
changes.
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NADH:ubiquinone oxidoreductase (complex I) is the ﬁrst enzyme
of the respiratory electron transport chain, providing a key entry
point for electrons. It oxidises NADH and reduces ubiquinone,
coupling the electron transfer to the translocation of protons across
the inner mitochondrial membrane; the proton electrochemical
potential generated here is utilised for ATP synthesis [1]. Mutations
in complex I account for approximately 30% of cases of mitochondrial
respiratory chain deﬁciencies in humans and hence contribute sig-
niﬁcantly to mitochondrial disorders with clinical phenotypes that
range from severe lactic acidosis in children to muscle weakness in
adults [2]. Mutations that occur in the 51 kDa subunit are particularly
relevant since this subunit contains the highly conserved ﬂavin and
NADH-binding site. Yarrowia lipolytica is an obligate aerobic yeast
and a powerful model for both structural and functional studies on
complex I [3]. It has a fully sequenced genome, a high content of
mitochondria with steady expression of complex I and the ability to
easily express mutations from a plasmid in a knockout strain. It also
contains similar supernumerary subunits to its mammalian counter-
part, making it a good model for studying human mutations. The
present work evaluates the use of Y. lipolytica as a model organism
to study pathologically relevant mutations at the ﬂavin site. The
impacts of these mutations on the function of complex I have been
assessed by characterising the ﬂavin and ubiquinone-site activities,
measuring the stability of the ﬂavin site and monitoring the pro-
duction of reactive oxygen species (ROS). The results will broaden
our understanding of how mutations at the ﬂavin site affect the
function of complex I and their relevance to mitochondrial dysfunc-
tion and related diseases.
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Complex I (NADH:ubiquinone oxidoreductase, type I) is the
electron input enzyme of the respiratory chain of mitochondria and
many bacteria. It transfers electrons from the donor, NADH, to the
acceptor, ubiquinone. This transfer of reducing equivalents is coupled
to translocation of 3 or 4 protons per 2 electrons across the mem-
brane. Among other enzymes of the respiratory chain, Complex I
is the most structurally complex and functionally enigmatic. To
reveal the molecular mechanism of a proton pump the identiﬁcation
of partial reactions of the respective catalytic cycle by following the
single turnover in real time is prerequisite. The homemade kinetic
spectrometer equipped with ultra-fast microﬂuidic stopped-ﬂow
setup was developed. The parameters of this setup such as low
sample consumption, ~0.007 ml per shot, and short dead time,
~0.25 ms, as well as the fast registration of the absorbance changes
not at a single wavelength but in particular wavelength range, give a
unique possibility to resolve optically the events upon a single
catalytic cycle. The data obtained by fast mixing of Complex I and
Abstracts e49
NADH indicated that the enzymatic reaction consists of two kinetic
components of the enzyme reduction: fast kinetics of the partial
reduction of FeS clusters with characteristic time shorter than the
dead time of stopped-ﬂow apparatus and slower phase of other FeS
cluster reduction with the resolved characteristic time of 0.7–0.9 ms.
These results are in good agreement with previous real time EPR
studies of Complex I by ultrafast freeze-quench approach [1–2].
References
[1] M.L. Verkhovskaya, N. Belevich, L. Euro, M. Wikström,
M.I. Verkhovsky, Proc. Natl. Acad. Sci USA 105 (2008) 3763–3767.
[2] N.P. Belevich, M.L. Verkhovskaya, M.I. Verkhovsky, Methods
Enzymol. 456 (2009) 75–93.
doi:10.1016/j.bbabio.2014.05.073
S4.P26
Mitochondrial and bio-energetic dysfunction in rat myocardium
in chronic heart failure
Rob C.I. Wüsta, H.J. de Vriesb, H.W.M. Niessena, G.J.M. Stienena
aInstitute for Cardiovascular Research, VU University Medical Centre,
The Netherlands
bInstitute for Cardiovascular Research, VU University Medical Centre,
Amsterdam, The Netherlands
E-mail address: r.wust@vumc.nl
In chronic heart failure (CHF), alterations occur in cardiac
metabolism, mitochondrial enzyme content and activities. However,
little is understood about the inﬂuence of alterations in mitochon-
drial function on bio-energetics and contractile function in heart
failure (HF). A photometry-based technique was used to simulta-
neously measure force and autoﬂuorescence of NADH and FAD in
intact cardiac trabeculae. Additional, high-resolution respirometry
was used to assess mitochondrial function in CHF.
Monocrotaline (60 mg.kg−1) was used to induce right ventricular
HF (n = 15) and compared to saline (CON; n = 15). After 23 ±
1 days hearts were excised and the right ventricular trabeculae were
attached to a force transducer. Autoﬂuorescence of NADH (excitation:
340 nm; emission: 460 nm) and FAD (ex: 450 nm; em: 525 nm) was
recorded during transitions in pacing frequency at 27 °C. Oxygen
consumption (JO2) of saponin-permeabilised ﬁbres was measured
by respirometry. Mitochondrial volume density and ultrastructure
were assessed by electron microscopy and ETS protein content was
determined by Western immunoblotting. Upon an increase in pacing
frequency from 0.5 to 3 Hz, tension-time integral (ΔTTI) increased less
in HF compared to CON (3.2 ± 0.2 vs. 5.6 ± 1.4 fold). The rapid drop
in NADHwas related to ΔTTI in CON (R2 = 0.887, P b 0.001), but not in
HF. Steady-state NADH at 3 Hz was higher in HF than in CON and also
higher than initial values (P b 0.001). FAD responses showed a mirror
image. Maximal complex I-stimulated JO2 was ~6 times higher in CON
than in CHF (P b 0.001). Maximal mitochondrial oxidative phosphory-
lation, by complex I and II respiration, was ~2.5 times higher in CON vs.
HF (87 ± 41 vs. 227 ± 28 pmol O2.mg−1.s−1). The lower ﬂux control
ratio in HF (0.42 ± 0.13) vs. 0.22 ± 0.15 (CON, P b 0.001) suggests
complex I dysfunction. ETS protein content (complex I/IV in CHF: 90.6%
of CON) and mitochondrial density (21.1 ± 1.2 vs. 20.8 ± 1.0%) were
not different in CON and CHF, butmitochondria in HF showed disturbed
ultrastructure. These results indicate a bio-energetic dysfunction in
HF. Mitochondrial respiration was more severely affected in HF than
that predicted from mitochondrial ETS protein content or density.
Mitochondrial complex I dysfunction, and other factors such as ultra-
structural alterations and mitochondrial super-complex destabilisation
are contributing to a bio-energetic limitation in CHF. Supported by
CVON2011-11 ARENA.
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